TY - JOUR
T1 - Trends in the incidence of head and neck cancer
T2 - A nationwide population-based study
AU - Yang, Tzong Hann
AU - Xirasagar, Sudha
AU - Cheng, Yen Fu
AU - Chen, Chin Shyan
AU - Chang, Wei Pin
AU - Lin, Herng Ching
N1 - Publisher Copyright:
© 2023 Elsevier Ltd
PY - 2023/5
Y1 - 2023/5
N2 - Objective: This study aimed to demonstrate the temporal trend in incidence of head and neck cancer (HNC) in Taiwan. Materials and methods: Patients with a HNC were retrieved from the Taiwan's Health Insurance Database. We identified 16,894 patients aged ≥20 years who had received a first-time diagnosis of cancer of the oral cavity, oropharynx, larynx, hypopharynx, nasopharynx, sinonasal, salivary gland or thyroid gland between 2010 and 2018. We calculated the annual incidence rate per 100,000 population, overall, and classified by gender and cancer type. We also used the annual percent change (APC) to characterize trends in head and neck cancer rates over time. Results: The incidence rate showed a gradual decline during this period from 2010 to 2018 with an APC of −2.81% (p < 0.001). Within gender groups, the decline was not statistically significant among females (APC = −1.69, 95% CI = −3.58 ∼ 0.23, p = 0.080). Within cancer types, strikingly high magnitude and statistically significant declines were observed in respect of cancer of the nasopharynx (APC = −7.89%, 95% CI = −9.43%∼−6.31%, p < 0.001), sinonasal cancer (APC = −10.08%, 95% CI = −16.66%∼−2.99%, p = 0.012) and oropharyneal cancer (APC = −9.47%, 95% CI = −15.15%∼−3.42%, p = 0.013) over the study period. In contrast, there was a statistically significant increase in incidence on thyroid cancer over the study period with an APC of 4.75% (95% CI = −2.81%∼6.75%, p < 0.001). Conclusions: HNCs in Taiwan are showing a decreasing trend, led by the upper respiratory and oropharyngeal cancers. However, there was a concurrent increasing trend of the incidence on thyroid cancer. These trends may be attributable to changing lifestyles and behavioral choices in Taiwan.
AB - Objective: This study aimed to demonstrate the temporal trend in incidence of head and neck cancer (HNC) in Taiwan. Materials and methods: Patients with a HNC were retrieved from the Taiwan's Health Insurance Database. We identified 16,894 patients aged ≥20 years who had received a first-time diagnosis of cancer of the oral cavity, oropharynx, larynx, hypopharynx, nasopharynx, sinonasal, salivary gland or thyroid gland between 2010 and 2018. We calculated the annual incidence rate per 100,000 population, overall, and classified by gender and cancer type. We also used the annual percent change (APC) to characterize trends in head and neck cancer rates over time. Results: The incidence rate showed a gradual decline during this period from 2010 to 2018 with an APC of −2.81% (p < 0.001). Within gender groups, the decline was not statistically significant among females (APC = −1.69, 95% CI = −3.58 ∼ 0.23, p = 0.080). Within cancer types, strikingly high magnitude and statistically significant declines were observed in respect of cancer of the nasopharynx (APC = −7.89%, 95% CI = −9.43%∼−6.31%, p < 0.001), sinonasal cancer (APC = −10.08%, 95% CI = −16.66%∼−2.99%, p = 0.012) and oropharyneal cancer (APC = −9.47%, 95% CI = −15.15%∼−3.42%, p = 0.013) over the study period. In contrast, there was a statistically significant increase in incidence on thyroid cancer over the study period with an APC of 4.75% (95% CI = −2.81%∼6.75%, p < 0.001). Conclusions: HNCs in Taiwan are showing a decreasing trend, led by the upper respiratory and oropharyngeal cancers. However, there was a concurrent increasing trend of the incidence on thyroid cancer. These trends may be attributable to changing lifestyles and behavioral choices in Taiwan.
KW - Epidemiology
KW - Head and neck cancer
KW - Incidence
KW - Oropharyneal cancer
KW - Sinonasal cancer
UR - http://www.scopus.com/inward/record.url?scp=85151732673&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85151732673&partnerID=8YFLogxK
U2 - 10.1016/j.oraloncology.2023.106391
DO - 10.1016/j.oraloncology.2023.106391
M3 - Article
C2 - 37030023
AN - SCOPUS:85151732673
SN - 1368-8375
VL - 140
JO - Oral Oncology
JF - Oral Oncology
M1 - 106391
ER -